Log in with your NetID to export as a spreadsheet. After you log in, you will need to re-select any search options you've chosen.
| Deadline | Title | Funding Agency | Discipline | Who's Eligible |
Award Amount |
Date Posted |
|---|---|---|---|---|---|---|
| Deadline: 2/16/2021 | Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $275,000 | 4/18/2022 |
| Deadline: 6/16/2021 | Pilot and Feasibility Clinical and Translational Research Studies in Digestive Diseases and Nutrition (R21 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $275,000 | 4/18/2022 |
| Deadline: 2/16/2021 | Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $275,000 | 4/18/2022 |
| Deadline: 11/09/2021 | Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $275,000 | 4/18/2022 |
| Deadline: 3/18/2020 | Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $275,000 | 4/18/2022 |
| Deadline: 12/06/2021 | Innate Immune Memory Impacting HIV Acquisition and/or Control (R21 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $275,000 | 4/18/2022 |
| Deadline: 7/08/2021 | Virtual Approaches Towards New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (U18 Clinical Trials Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $800,000 | 4/18/2022 |
| Deadline: 1/25/2022 | Development of Research Education Resources for Geriatrics-Related Translational and Clinical Scientists (R25 Independent Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $900,000 | 4/18/2022 |
| Deadline: 9/14/2021 | Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $900,000 | 4/18/2022 |
| Deadline: 2/08/2022 | Ethical Issues in Translational Science Research (R01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $1,200,000 | 4/18/2022 |
| Deadline: 6/24/2021 | Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $1,250,000 | 4/18/2022 |
| Deadline: 3/03/2021 | Understanding the Cellular and Molecular Mechanisms of Gastroparesis in Adults and Children (R01 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $1,250,000 | 4/18/2022 |
| Deadline: 11/12/2020 | Genomic Data Analysis Network: Genomic Data Center (U24 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $1,500,000 | 4/18/2022 |
| Deadline: 12/18/2020 | NIH Blueprint for Neuroscience Research: Functional Neural Circuits of Interoception (R01, Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $1,875,000 | 4/18/2022 |
| Deadline: 4/01/2020 | Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,200,000 | 4/18/2022 |
| Deadline: 9/14/2021 | Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,500,000 | 4/18/2022 |
| Deadline: 6/05/2021 | NIAMS -- Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R01, R21 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,500,000 | 4/18/2022 |
| Deadline: 11/13/2020 | Using Human Cell Animal Chimera Brains to Study HIV Latency and Pathology R01 - Clinical Trials Not Allowed | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,500,000 | 4/18/2022 |
| Deadline: 3/08/2022 | Pediatric Obesity Discovery Science Research to Improve Understanding of Risk and Causal Mechanisms for Obesity in Early Life (R01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,500,000 | 4/18/2022 |
| Deadline: 3/10/2022 | HEAL Initiative: Understanding Polysubstance Use and Improving Service Delivery to Address Polysubstance Use (R01, R34 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,500,000 | 4/18/2022 |
